Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for Anemia in Non-Myeloid Malignancies
NCT05301517Phase 3Completed
- Sponsor
- FibroGen
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in Chemotherapy-induced anemia (CIA), sponsored by FibroGen. Started Mar 2022; status: completed.
02
Drugs
roxadustat
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT05301517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05301517.